1. Editor's introduction

   Modern Concepts in the Treatment of Ischemic Heart Disease Pages: 7 - 7

2. Ischemia at the crossroads?

   • David J. Hearse

   Part One: Editorial Comment Pages: 9 - 15

3. Time course of myocardial necrosis

   • Jutta Schaper
   • Wolfgang Schaper

   Part Two: Basic Concept Pages: 17 - 25

4. Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy

   • Eberhard Bassenge
   • Duncan J. Stewart

   Part Two: Basic Concept Pages: 27 - 34

5. Pathophysiology of myocardial ischemia: Importance of platelet-vessel wall interactions

   • James Roy Parratt

   Part Two: Basic Concept Pages: 35 - 40

6. Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography

   • Luis I. Araujo
   • Paolo Camici
   • Attilio Maseri

   Part Two: Basic Concept Pages: 41 - 46

7. The combination of antianginal drugs: Effects and indications

   • Paul Robert Lichtlen

   Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 47 - 60

8. Silent ischemia: A relevant problem in patients with coronary artery disease?

   • W. Rutishauser
   • A. Righetti
   • P. Roy

   Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 61 - 65

9. Indications for treatment of silent myocardial ischemia

   • Peter F. Cohn

   Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 67 - 69

10. Nonresponsiveness to antianginal therapy—A frequent problem?

    • Wolfgang Schulz

    Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 71 - 77

11. Preload or afterload reduction: Which is more beneficial for patients with ischemic heart disease?

    • Dennis G. Caralis
    • Z. Kyriakides

    Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 79 - 82

12. Combination of positive inotropic and vasodilating substances in congestive heart failure

    • Ivano Cantelli
    • Daniele Bracchetti

    Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 83 - 91

13. Indications for coronary angioplasty in acute myocardial ischemic syndromes

    • Pim J. de Feyter
    • Patrick W. Serruys
    • Paul G. Hugenholtz

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 93 - 101

14. Which role for antiplatelet and anticoagulant drugs in unstable angina pectoris?

    • H. Daniel Lewis Jr

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 103 - 106

15. Additional molsidomine in refractory unstable angina pectoris

    • O. Bertel
    • G. Noll

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 107 - 111

16. According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

    • John K. Kjekshus

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 113 - 119

17. What is established in thrombolytic therapy of acute myocardial infarction? Pharmacological approaches

    • Wolfgang Kübler
    • Christoph Bode
    • Franz Schwarz

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 121 - 125

18. The influence of molsidomine on infarct size: An acute post-infarction pilot study with 303 patients

    • P. Beaufils
    • H. Kolsky
    • R. Slama

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 127 - 132

19. Risk factor intervention and prognosis after acute myocardial infarction

    • G Lamm

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 133 - 137

20. Secondary prevention after myocardial infarction: Effects of beta blocking agents and calcium antagonists

    • P. Depelchin
    • J. Sobolski
    • C. Flament

    Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 139 - 147

21. Editor's note

    EditorialNotes Pages: 148 - 148

22. Summary of oral presentations

    Abstract Pages: 149 - 153

23. Announcement

    Announcement Pages: i - i